COVID-Vac Combined Vector Vaccine(Hetero)

N/A

Report date: 2025/01/16 15:10:32

Base Information

Drug NameCOVID-Vac Combined Vector Vaccine(Hetero)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHetero Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHetero Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A